novo nordisk glp-1 patent litigation The wars are heating up. (NVO) is suing rival Eli Lilly (LLY), alleging the drugmaker used outdated clinical trial data in advertising to make its weight loss and diabetes The Heavy Price of GLP-1

Drugs 81:963969 Dhillon S (2022) Tebentafusp: first approval

Powerful Antioxidant: Glutathione is celebrated as one of the body's most potent antioxidants, playing a crucial role in neutralizing harmful free radicals, reducing oxidative stress, and supporting detoxification processes

References Frontiers | Publisher of peer-reviewed articles in open access journals Semaglutide Mechanism of Action John Wilding, Rachel Batterham, Salvatore Calanna, et al

Theres a lot to cover, so lets get started

Combined use demands regular monitoring of liver function, lipase, and blood glucose, especially in patients with history of pancreatitis, personal/family thyroid cancer, or unstable renal function

PMCID: PMC3651682.